Autologous NK Cell(Xiangyang No.1 People'S Hospital)

自体NK细胞(襄阳第一人民医院)

Report date: 2024/03/29 20:06:02

Base Information

Drug NameAutologous NK Cell(Xiangyang No.1 People'S Hospital)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy

Mechanisms of ActionCell replacementsImmunologic cytotoxicity

TargetsNot applicable

Therapy Area/IndicationsLymphoma, B-Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaPhase 2 Clinical

Originator CompaniesXiangyang No.1 People'S Hospital, Hubei University Of Medicine

China Registration ClassN/A

Develop Information

Active CompaniesXiangyang No.1 People'S Hospital, Hubei University Of Medicine

Inactive CompaniesN/A

Active IndicationsLymphoma, B-Cell

Inactive IndicationsN/A

Other Information

ATC CodeN/A